High dose flu shot no better than standard one in high risk CVD patients: JAMA
Researchers have observed in a new study that in patients with high-risk cardiovascular disease, high-dose trivalent influenza vaccine, compared with the standard-dose quadrivalent vaccine, did not significantly reduce all-cause mortality or hospitalizations for cardiac or pulmonary causes.High-dose influenza vaccine is not superior to standard-dose vaccine in high-risk adults with cardiovascular disease (CVD).
This study is published in the JAMA Network.
For further reference log on to:
JAMA. Published online December 4, 2020. doi:10.1001/jama.2020.23649